SCHEMBL19408166

SCHEMBL19408166

Clc1cc(Cl)cc(COOC2CCCN(c3nc4nc(Cl)ccc4[nH]3)C2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.46
DGAT2 Q96PD7 7/20 0.36
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
RAB9A P51151 1/20 0.34
GFER P55789 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAOB P27338 1/20 0.33
HTR6 P50406 1/20 0.33
PRMT5 O14744 2/20 0.32
TRPC3 Q13507 1/20 0.32
ROCK2 O75116 5/20 0.32
CCR2 P41597 3/20 0.32
ROCK1 Q13464 3/20 0.32
PRKG1 Q13976 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17513335 0.90 GRIN2B (0.47) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17513284 0.79 GRIN2B (0.53) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17513287 0.79 GRIN2B (0.53) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17533803 0.79 GRIN2B (0.53) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL19408132 0.79 GRIN2B (0.47) GRIN2BDGAT2NPC1RAB9AMAOB
SCHEMBL17533830 0.78 GRIN2B (0.47) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17533790 0.78 GRIN2B (0.47) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17533949 0.78 GRIN2B (0.47) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17533789 0.77 GRIN2B (0.50) GRIN2BDGAT2NPC1TP53HPGD
SCHEMBL17533827 0.76 GRIN2B (0.44) GRIN2BDGAT2NPC1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913736-B2 Specific inhibitors of methionyl-tRNA synthetase UNIVERSITY OF WASHINGTON (US) 2021-02-09 US disclosed
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE UNIVERSITY OF WASHINGTON 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE AARS1, MTR, GARS1 GRIN2B 1938/4885DGAT2 2308/4885NPC1 3420/4885
US-10913736-B2 Specific inhibitors of methionyl-tRNA synthetase AARS1, MTR, GARS1 GRIN2B 1938/4885DGAT2 2308/4885NPC1 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.